Stocks · Korea
002630
KOSPI
Orientbio
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-5.09%
1M-14.31%
3M-12.08%
6M-35.02%
1Y-35.65%
YTD-36.49%
52W high3,460원
52W low—
From 52W high-52.05%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2021 | 520억 | 19억 | -156억 | 3.6% |
| Quarterly | ||||
| 2021 1Q | 135억 | 7억 | 27억 | 4.9% |
| 2021 2Q | 145억 | -4억 | -2억 | -2.6% |
| 2021 3Q | 172억 | 10억 | 9억 | 5.9% |
| 2021 4Q | 68억 | 6억 | -190억 | 8.4% |
Company
Address: 경기 성남시 중원구 상대원동 143-1
Peers in the same sector
Recent filings
- 2026-08-14분기보고서 (2026.06)
- 2026-06-23주요사항보고서(감자결정) Major
- 2026-06-19[기재정정]사업보고서 (2026.03)
- 2026-06-19사업보고서 (2026.03)
- 2026-02-13분기보고서 (2025.12)
- 2025-12-02주요사항보고서(자기주식처분결정) Major
- 2025-11-14반기보고서 (2025.09)
- 2025-08-13분기보고서 (2025.06)
- 2025-06-19사업보고서 (2025.03)
- 2025-06-13[기재정정]사업보고서 (2019.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.